Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9340786 RNA interference in dermal and fibrotic indications

Patent 9340786 was granted and assigned to Rxi Pharmaceuticals Corporation on May, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 4 Sep, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 4 Sep, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12077755 Bioactive conjugates for oligonucleotide delivery
0
Edits on 31 Jul, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 31 Jul, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 4 Jul, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 4 Jul, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12024706 Modified oligonucleotides targeting SNPs
0
Edits on 14 Mar, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 14 Mar, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11926828 Methods for treating aging and skin disorders using nucleic acids targeting TYR or MMP1
0
Edits on 5 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 5 Dec, 2023
Edits made to:
Article (+195 characters)
Article

Patent abstract

The present invention relates to RNAi constructs with improved tissue and cellular uptake characteristics and methods of use of these compounds in dermal and fibrotic applications.

Edits on 29 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 29 Sep, 2023
Edits made to:
Infobox (+9 properties)
Infobox
Patent Inventor Names
Anastasia Khvorova0
Dmitry Samarsky0
James Cardia0
Joanne Kamens0
Karen G. Bulock0
Lyn Libertine0
Pamela A. Pavco0
Tod M. Woolf0
William Salomon0
Edits on 27 Sep, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11767527 Modified oligonucleotides targeting SNPs
Edits on 13 Sep, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Sep, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11753638 Conjugated oligonucleotides
Edits on 19 Jul, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 Jul, 2023
Edits on 14 Jul, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 14 Jul, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 09340786 RNA interference in dermal and fibrotic indications US Patent 9340786 RNA interference in dermal and fibrotic indications

Infobox
Patent Number
093407860
Patent Number
93407860
Edits on 18 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 18 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=093407860
Edits on 27 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 27 Mar, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
‌
Rxi Pharmaceuticals Corporation
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
093407860
Date of Patent
May 17, 2016
0
Patent Application Number
136367550
Date Filed
March 24, 2011
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=093407860
Patent Primary Examiner
‌
Amy Bowman
0
Edits on 17 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 17 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=09340786
Edits on 6 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 6 Jan, 2022
Edits made to:
Infobox (+8 properties)
‌

 US Patent 09340786 RNA interference in dermal and fibrotic indications

Infobox
Is a
Patent
Patent
Current assignee
‌
Rxi Pharmaceuticals Corporation
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
09340786
Date of patent
May 17, 2016
Patent application number
13636755
Date Filed
March 24, 2011
Patent primary examiner
‌
Amy Bowman

Find more entities like US Patent 9340786 RNA interference in dermal and fibrotic indications

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.